LH · Labcorp Holdings Inc
Price
Snapshot
50 fields · last close| Market Cap | $25.44B |
| P/E | 25.38 |
| Float | 80.56M |
| Beta | 0.89 |
| Volatility | 22.4% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 83.2 |
| Price | 318.16 |
| Change | +1.44% |
| Prev Close | 313.64 |
| Open | 316.70 |
| Day Low | 312.22 |
| Day High | 319.30 |
| Avg Vol | 1 |
| Avg $ Vol | $199.6M |
| 52W High | 341.80 |
| 52W Low | 244.52 |
| 52W Pos | 75.7% |
| From High | −6.92% |
| From Low | +30.12% |
| Max DD 1Y | −15.22% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +1.80% |
| SMA 50 | −0.60% |
| SMA 200 | +12.67% |
| RSI (14) | 49.6 |
| Vol 30D | 23.3% |
| Vol 90D | 24.0% |
| 1Y Range | 245–342 |
| Daily bars | 533 |
| Perf Week | +0.62% |
| Perf Month | −0.53% |
| Perf Quarter | +15.31% |
| Perf Half Y | +16.65% |
| Perf Year | +12.87% |
| Perf YTD | +26.42% |
| Prev Day | +1.44% |
| Clavix | A- |
| Debt / Eq | 0.72 |
| Curr Ratio | 1.42 |
| Int Cover | 6.2× |
| FCF Margin | 8.6% |
| Rev Growth | +7.2% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 4 / 49 |
What LH does
Labcorp Holdings Inc. provides laboratory services.
It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests.
It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations.
In addition, the company offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI‑enabled Test Selection, a generative AI‑enabled tool.
It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs.
The company has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics.
It also has a collaboration with Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer.
The company was founded in 1995 and is headquartered in Burlington, North Carolina.
Clavix risk grade
regraded every trading dayLH grades A-, 83.2 of 100. Steadiest on Price Stability (68), most exposed on Sector Resilience (64, mixed). 3 of the 4 weighted dimensions sit above the Health Care median. Ranks 4 of 49 in Health Care by Clavix score.
How rough the ride is
| LH | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.89 | 0.85 |
| Volatilityannualized | 22.4% | 21.3% |
| Max drawdown, past yearworst peak-to-trough fall | −15.2% | — |
| Typical daily movemedian absolute daily change | 0.89% | — |
| Days beyond ±3%of the last 252 sessions | 12 (5%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| LH | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.89 | 0.85 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| LH | |
|---|---|
| 1 week | +0.6% |
| 1 month | −0.5% |
| Year to date | +26.4% |
| 1 year | +12.9% |
Context for the rank, not itself a risk measure.
No scored coverage for LH in the recent pool.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| LH | |
|---|---|
| Revenue growthyear over year | +7.2% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| DGX | Quest Diagnostics Inc | A- | $25.44B | 24.12 | 0.56 | Compare |
| ALC | Alcon AG | B+ | $26.70B | 39.16 | 1.11 | Compare |
| GH | Guardant Health Inc | C+ | $21.75B | — | 1.69 | Compare |
| THC | Tenet Healthcare Corp | B | $21.49B | 9.62 | 1.23 | Compare |
| STE | STERIS plc | A- | $21.23B | 26.40 | 0.88 | Compare |
| GEHC | GE Healthcare Technologies Inc | B | $31.07B | 15.65 | 0.85 | Compare |
| DXCM | Dexcom Inc | B | $32.10B | 32.37 | 1.44 | Compare |
| RMD | Resmed Inc | B+ | $33.06B | 21.70 | 0.78 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.